Your browser doesn't support javascript.
loading
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.
Krebs, Alice; van Vugt-Lussenburg, Barbara M A; Waldmann, Tanja; Albrecht, Wiebke; Boei, Jan; Ter Braak, Bas; Brajnik, Maja; Braunbeck, Thomas; Brecklinghaus, Tim; Busquet, Francois; Dinnyes, Andras; Dokler, Joh; Dolde, Xenia; Exner, Thomas E; Fisher, Ciarán; Fluri, David; Forsby, Anna; Hengstler, Jan G; Holzer, Anna-Katharina; Janstova, Zofia; Jennings, Paul; Kisitu, Jaffar; Kobolak, Julianna; Kumar, Manoj; Limonciel, Alice; Lundqvist, Jessica; Mihalik, Balázs; Moritz, Wolfgang; Pallocca, Giorgia; Ulloa, Andrea Paola Cediel; Pastor, Manuel; Rovida, Costanza; Sarkans, Ugis; Schimming, Johannes P; Schmidt, Bela Z; Stöber, Regina; Strassfeld, Tobias; van de Water, Bob; Wilmes, Anja; van der Burg, Bart; Verfaillie, Catherine M; von Hellfeld, Rebecca; Vrieling, Harry; Vrijenhoek, Nanette G; Leist, Marcel.
Afiliação
  • Krebs A; In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Universitaetsstr. 10, 78457, Konstanz, Germany.
  • van Vugt-Lussenburg BMA; Konstanz Research School Chemical Biology, University of Konstanz, 78457, Konstanz, Germany.
  • Waldmann T; BioDetection Systems BV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.
  • Albrecht W; In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Universitaetsstr. 10, 78457, Konstanz, Germany.
  • Boei J; trenzyme GmbH, Byk-Gulden-Str. 2, 78467, Konstanz, Germany.
  • Ter Braak B; Leibniz-Institut für Arbeitsforschung an der TU Dortmund, Leibniz Research Center for Working Environment and Human Factors (IfADo), Ardeystraße 67, 44139, Dortmund, Germany.
  • Brajnik M; Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
  • Braunbeck T; Division of Drug Discovery and Safety, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
  • Brecklinghaus T; Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, 4057, Basel, Switzerland.
  • Busquet F; Aquatic Ecology and Toxicology Group, Center for Organismal Studies, University of Heidelberg, Im Neuenheimer Feld 504, 69120, Heidelberg, Germany.
  • Dinnyes A; Leibniz-Institut für Arbeitsforschung an der TU Dortmund, Leibniz Research Center for Working Environment and Human Factors (IfADo), Ardeystraße 67, 44139, Dortmund, Germany.
  • Dokler J; CAAT Europe, University of Konstanz, Steinbeis SU-1866, 78457, Konstanz, Germany.
  • Dolde X; BioTalentum Ltd., Aulich Lajos str. 26, Gödöllo, 2100, Hungary.
  • Exner TE; Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, 4057, Basel, Switzerland.
  • Fisher C; In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Universitaetsstr. 10, 78457, Konstanz, Germany.
  • Fluri D; Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, 4057, Basel, Switzerland.
  • Forsby A; Simcyp Division, Certara UK Limited, Level 2-Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.
  • Hengstler JG; InSphero AG, Wagistrasse 27, 8952, Schlieren, Switzerland.
  • Holzer AK; Unit of Toxicology Sciences, Swedish Toxicology Sciences Research Center (Swetox), Karolinska Institutet, Forskargatan 20, 151 36, Södertälje, Sweden.
  • Janstova Z; Department of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden.
  • Jennings P; Leibniz-Institut für Arbeitsforschung an der TU Dortmund, Leibniz Research Center for Working Environment and Human Factors (IfADo), Ardeystraße 67, 44139, Dortmund, Germany.
  • Kisitu J; In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Universitaetsstr. 10, 78457, Konstanz, Germany.
  • Kobolak J; BioTalentum Ltd., Aulich Lajos str. 26, Gödöllo, 2100, Hungary.
  • Kumar M; Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
  • Limonciel A; In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Universitaetsstr. 10, 78457, Konstanz, Germany.
  • Lundqvist J; Konstanz Research School Chemical Biology, University of Konstanz, 78457, Konstanz, Germany.
  • Mihalik B; BioTalentum Ltd., Aulich Lajos str. 26, Gödöllo, 2100, Hungary.
  • Moritz W; Department of Development and Regeneration, Stem Cell Biology and Embryology, Stem Cell Institute Leuven, KU Leuven, O&N IV Herestraat 49, 3000, Leuven, Belgium.
  • Pallocca G; Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
  • Ulloa APC; Unit of Toxicology Sciences, Swedish Toxicology Sciences Research Center (Swetox), Karolinska Institutet, Forskargatan 20, 151 36, Södertälje, Sweden.
  • Pastor M; Department of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden.
  • Rovida C; BioTalentum Ltd., Aulich Lajos str. 26, Gödöllo, 2100, Hungary.
  • Sarkans U; InSphero AG, Wagistrasse 27, 8952, Schlieren, Switzerland.
  • Schimming JP; CAAT Europe, University of Konstanz, Steinbeis SU-1866, 78457, Konstanz, Germany.
  • Schmidt BZ; Unit of Toxicology Sciences, Swedish Toxicology Sciences Research Center (Swetox), Karolinska Institutet, Forskargatan 20, 151 36, Södertälje, Sweden.
  • Stöber R; Department of Experimental and Health Sciences, Research Programme on Biomedical Informatics (GRIB), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, 08003, Barcelona, Spain.
  • Strassfeld T; CAAT Europe, University of Konstanz, Steinbeis SU-1866, 78457, Konstanz, Germany.
  • van de Water B; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.
  • Wilmes A; Leiden Academic Center for Drug Research, LACDR/Toxicology, Leiden University, PO Box 9500, 2300 RA, Leiden, The Netherlands.
  • van der Burg B; Switch Laboratory, Department of Cellular and Molecular Medicine, VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
  • Verfaillie CM; Leibniz-Institut für Arbeitsforschung an der TU Dortmund, Leibniz Research Center for Working Environment and Human Factors (IfADo), Ardeystraße 67, 44139, Dortmund, Germany.
  • von Hellfeld R; InSphero AG, Wagistrasse 27, 8952, Schlieren, Switzerland.
  • Vrieling H; Leiden Academic Center for Drug Research, LACDR/Toxicology, Leiden University, PO Box 9500, 2300 RA, Leiden, The Netherlands.
  • Vrijenhoek NG; Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
  • Leist M; BioDetection Systems BV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.
Arch Toxicol ; 94(7): 2435-2461, 2020 07.
Article em En | MEDLINE | ID: mdl-32632539
ABSTRACT
Hazard assessment, based on new approach methods (NAM), requires the use of batteries of assays, where individual tests may be contributed by different laboratories. A unified strategy for such collaborative testing is presented. It details all procedures required to allow test information to be usable for integrated hazard assessment, strategic project decisions and/or for regulatory purposes. The EU-ToxRisk project developed a strategy to provide regulatorily valid data, and exemplified this using a panel of > 20 assays (with > 50 individual endpoints), each exposed to 19 well-known test compounds (e.g. rotenone, colchicine, mercury, paracetamol, rifampicine, paraquat, taxol). Examples of strategy implementation are provided for all aspects required to ensure data validity (i) documentation of test methods in a publicly accessible database; (ii) deposition of standard operating procedures (SOP) at the European Union DB-ALM repository; (iii) test readiness scoring accoding to defined criteria; (iv) disclosure of the pipeline for data processing; (v) link of uncertainty measures and metadata to the data; (vi) definition of test chemicals, their handling and their behavior in test media; (vii) specification of the test purpose and overall evaluation plans. Moreover, data generation was exemplified by providing results from 25 reporter assays. A complete evaluation of the entire test battery will be described elsewhere. A major learning from the retrospective analysis of this large testing project was the need for thorough definitions of the above strategy aspects, ideally in form of a study pre-registration, to allow adequate interpretation of the data and to ensure overall scientific/toxicological validity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxicologia / Processamento Eletrônico de Dados / Testes de Toxicidade / Regulamentação Governamental / Documentação Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxicologia / Processamento Eletrônico de Dados / Testes de Toxicidade / Regulamentação Governamental / Documentação Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article